← Back to directory

Xiaoguang Lei

Researcher Next ID · RN-020019

Researcher · Medicine

King University

Bristol, Thailand

Not currently recruitingFunding unknown
Works count
319
Citation count
12,501
H-index
53
i10-index
167

Research interests

Medicine
Chemistry
Biochemistry, Genetics and Molecular Biology
Microbial Natural Products and Biosynthesis
Synthetic Organic Chemistry Methods
Marine Sponges and Natural Products
Click Chemistry and Applications
Chemical synthesis and alkaloids

Publications

  • Characterization and heterologous reconstitution of Taxus biosynthetic enzymes leading to baccatin III

    Science · 2024 · 10.1126/science.adj3484

  • Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target

    Science · 2023 · 10.1126/science.add5787

  • A small-molecule cocktail promotes mammalian cardiomyocyte proliferation and heart regeneration

    Cell stem cell · 2022 · 10.1016/j.stem.2022.03.009

  • An Arabidopsis Secondary Metabolite Directly Targets Expression of the Bacterial Type III Secretion System to Inhibit Bacterial Virulence

    Cell Host & Microbe · 2020 · 10.1016/j.chom.2020.03.004

  • Late-Stage Diversification of Natural Products

    ACS Central Science · 2020 · 10.1021/acscentsci.9b00916

  • Click-ExM enables expansion microscopy for all biomolecules

    Nature Methods · 2020 · https://doi.org/10.1038/s41592-020-01005-2

  • FAD-dependent enzyme-catalysed intermolecular [4+2] cycloaddition in natural product biosynthesis

    Nature Chemistry · 2020 · 10.1038/s41557-020-0467-7

  • MRGPRX4 is a bile acid receptor for human cholestatic itch

    eLife · 2019 · 10.7554/elife.48431

  • Chemoproteomic Profiling of Bile Acid Interacting Proteins

    ACS Central Science · 2017 · 10.1021/acscentsci.7b00134

  • Trifunctional cross-linker for mapping protein-protein interaction networks and comparing protein conformational states

    eLife · 2016 · 10.7554/elife.12509

  • Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome

    Journal of Medicinal Chemistry · 2016 · 10.1021/acs.jmedchem.6b01196

  • Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis

    Cell chemical biology · 2016 · 10.1016/j.chembiol.2015.08.018

  • Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine

    Nature Communications · 2015 · 10.1038/ncomms7522

  • A Bioorthogonal Ligation Enabled by Click Cycloaddition of o-Quinolinone Quinone Methide and Vinyl Thioether

    Journal of the American Chemical Society · 2013 · 10.1021/ja401989p

  • Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

    Cell · 2012 · https://doi.org/10.1016/j.cell.2011.11.031

  • Small-molecule activation of the TRAIL receptor DR5 in human cancer cells

    Nature Chemical Biology · 2012 · 10.1038/nchembio.1153

  • Total Syntheses of Lycopodium Alkaloids (+)‐Fawcettimine, (+)‐Fawcettidine, and (−)‐8‐Deoxyserratinine

    Angewandte Chemie International Edition · 2011 · 10.1002/anie.201106753

  • Crystal structure of the FTO protein reveals basis for its substrate specificity

    Nature · 2010 · 10.1038/nature08921

  • Chemical probing reveals insights into the signaling mechanism of inflammasome activation

    Cell Research · 2010 · 10.1038/cr.2010.135

Current projects

    No projects listed.